#184 - AMA #29: GLP-1 Agonists—The Future of Treating Obesity?
The Peter Attia Drive15 Marras 2021

#184 - AMA #29: GLP-1 Agonists—The Future of Treating Obesity?

In this "Ask Me Anything" (AMA) episode, Peter and Bob discuss all things related to GLP-1 agonists—a class of drugs that are gaining popularity for the treatment of obesity. They cover the discovery of these peptides, their physiology, and what it is they do in their natural state. Next, Peter and Bob break down a recently published study which showed remarkable results for weight loss and other metabolic parameters using a once-weekly injection of the GLP-1 agonist drug semaglutide, also known as Ozempic, in overweight and obese patients. Finally, they compare results from the semaglutide study to results from various lifestyle interventions and give their take on the potential future of GLP-1 agonists.

If you're not a subscriber and listening on a podcast player, you'll only be able to hear a preview of the AMA. If you're a subscriber, you can now listen to this full episode on your private RSS feed or on our website at the AMA #29 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

We discuss:

  • Remarkable results of a recent study in overweight adults [2:15];
  • Key background on insulin, glucagon and the incretin effect [4:00];
  • What is GLP-1 and how does it work? [16:30];
  • 2021 semaglutide study: remarkable results, side effects, and open questions [30:00];
  • Semaglutide vs. lifestyle interventions: comparing results with semaglutide vs. lifestyle interventions alone [44:00];
  • Closing thoughts and open questions on the therapeutic potential of semaglutide [47:30]; and
  • More
Learn more: https://peterattiamd.com/
Show notes page for this episode: https://peterattiamd.com/ama29/
Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/
Connect with Peter on Facebook | Twitter | Instagram.

Jaksot(434)

#09 - David Sabatini, M.D., Ph.D.: rapamycin and the discovery of mTOR — the nexus of aging and longevity?

#09 - David Sabatini, M.D., Ph.D.: rapamycin and the discovery of mTOR — the nexus of aging and longevity?

In this episode, my good friend David Sabatini delves into his extensive work with the mechanistic target of rapamycin—better known as mTOR—and rapamycin. The compound rapamycin is the only known phar...

13 Elo 20181h 11min

#08 - Tom Bilyeu: nutrition, fasting, meditation, mindset, immortality, and the secret formula of fulfillment

#08 - Tom Bilyeu: nutrition, fasting, meditation, mindset, immortality, and the secret formula of fulfillment

Tom Bilyeu is the founder of Impact Theory and a co-founder of Quest Nutrition. In this episode, among the highlights, Tom provides powerful insight he's gained through his pursuit of fulfillment whic...

6 Elo 20181h 38min

#07 - Deep Dive: Lp(a) — what every doctor, and the 10-20% of the population at risk, needs to know

#07 - Deep Dive: Lp(a) — what every doctor, and the 10-20% of the population at risk, needs to know

Pronounced, el-pee-little-a, this lipoprotein is simply described as a low density lipoprotein (LDL) that has an apoprotein "a" attached to it...but Lp(a) goes far beyond its description in terms of i...

30 Heinä 20181h 16min

#06 - D.A. Wallach: music, medicine, cancer screening, and disruptive technologies

#06 - D.A. Wallach: music, medicine, cancer screening, and disruptive technologies

D.A. Wallach is a true polymath: recording artist, songwriter, essayist, investor, and so much more. In this episode, among the highlights, D.A. provides compelling and colorful insight into how the m...

23 Heinä 20182h 19min

#05 - Dom D'Agostino, Ph.D.: ketosis, n=1, exogenous ketones, HBOT, seizures, and cancer

#05 - Dom D'Agostino, Ph.D.: ketosis, n=1, exogenous ketones, HBOT, seizures, and cancer

Dom digs deep into the research and application of ketogenic diets, exogenous ketones, hyperbaric oxygen treatment, and treating cancer with a metabolic approach. Plus, we lost track of the number of ...

16 Heinä 20182h 43min

#04 - AMA #1: alcohol, best lab tests, wearables, finding the right doc, racing, and more

#04 - AMA #1: alcohol, best lab tests, wearables, finding the right doc, racing, and more

In his first "Ask Me Anything" episode, Peter answered your questions submitted to him via Twitter. We discuss: What are Peter's thoughts on alcohol consumption and health? [4:00] What are the best l...

9 Heinä 20182h 13min

#03 - Ron Krauss, M.D.: a deep dive into heart disease

#03 - Ron Krauss, M.D.: a deep dive into heart disease

Whenever I'm stumped on a patient case or in my thinking about lipids, Ron is one of the first people I turn to for insight. Ron is recognized globally for his research into lipidology and has worn ma...

2 Heinä 20181h 56min

#02 - Rhonda Patrick, Ph.D.: the performance and longevity paradox of IGF-1, ketogenic diets and genetics, the health benefits of sauna, NAD+, and more

#02 - Rhonda Patrick, Ph.D.: the performance and longevity paradox of IGF-1, ketogenic diets and genetics, the health benefits of sauna, NAD+, and more

Rhonda and I go on a Nerd Safari into the jungle of health, nutrition, fitness, performance, and longevity. We visit IGF-1 and whether there's a tradeoff of having high or low levels. We discuss the P...

2 Heinä 20181h 49min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
tiedenaiset-podcast
rss-pitaisko-erota
puhu-muru
rss-narsisti
terapiassa
rss-kuumilla-aalloilla
rss-uplevel-by-sonja-hannus
junnut-pelissa
rss-rakas-mielenterveyteni
katilon-kahvitunti
meditaatiot-suomeksi
selviytyjat-tarinoita-elamasta
rss-duodecim-lehti
rss-ehjaksi
rss-vapaudu-voimaasi
rss-kyykkya-ja-kuoharia